About POINT Biomedical
POINT Biomedical is a company based in San Carlos (United States) founded in 1996. It operates as a B2B. POINT Biomedical has raised $56.4 million across 3 funding rounds from investors including Credit Suisse, Frazier Healthcare Partners and De Novo Ventures. POINT Biomedical operates in a competitive market with competitors including Biological Dynamics, Conavi, miDiagnostics, Nanosphere and Anteo Tech, among others.
- Headquarter San Carlos, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$56.4 M (USD)
in 3 rounds
-
Latest Funding Round
$25 M (USD), Series E
Jan 01, 2008
-
Investors
Credit Suisse
& 11 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of POINT Biomedical
POINT Biomedical has successfully raised a total of $56.4M across 3 strategic funding rounds. The most recent funding activity was a Series E round of $25 million completed in January 2008. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in POINT Biomedical
POINT Biomedical has secured backing from 12 investors, including venture fund and institutional investors. Prominent investors backing the company include Credit Suisse, Frazier Healthcare Partners and De Novo Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
A biotechnology venture capital firm investing in innovative science.
|
Locked | Locked | Locked | |
|
Early stage healthcare services investments are facilitated by CHL.
|
Locked | Locked | Locked |
Investor details for POINT Biomedical
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by POINT Biomedical
Investment portfolio details for POINT Biomedical
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - POINT Biomedical
Detailed financials for POINT Biomedical
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Point Biomedical Comparisons
Peer comparison for POINT Biomedical
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of POINT Biomedical
POINT Biomedical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Biological Dynamics, Conavi, miDiagnostics, Nanosphere and Anteo Tech, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Proprietary lab-on-chip platform for nanoparticle isolation is offered.
|
|
| Locked | Locked | Locked |
Catheter-based ultrasound systems for cardiac imaging are developed.
|
|
| Locked | Locked | Locked |
Disposable chips are developed for rapid point-of-care blood diagnostics.
|
|
| Locked | Locked | Locked |
Diagnostic tests for personalized medicine targeting infections are provided.
|
|
| Locked | Locked | Locked |
Coupling reagents are developed for biomolecules immobilization on surfaces.
|
|
| Locked | Locked | Locked |
Coronary imaging and plaque detection system
|
Detailed competitors of POINT Biomedical
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Point Biomedical
Complete news archive for POINT Biomedical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about POINT Biomedical
POINT Biomedical was founded in 1996 and raised its 1st funding round 8 years after it was founded.
POINT Biomedical is headquartered in San Carlos, United States. It is registered at San Carlos, California, United States.
POINT Biomedical is a funded company, having raised a total of $56.4M across 3 funding rounds to date.
POINT Biomedical, established in 1996 and currently in Dissolved stage, focuses on healthcare and life sciences, developing medical devices, diagnostic imaging, and cardiovascular tools. Offers a product for cardiologists to conduct myocardial perfusion imaging studies. Adapting to market demands with innovation and client-focused strategies.
POINT Biomedical's top competitors include Conavi, miDiagnostics and Biological Dynamics.
POINT Biomedical has 12 investors. Key investors include Credit Suisse, Frazier Healthcare Partners, De Novo Ventures, Invesco, and SR One.